Search

everythinglearnresearchcommunity

for

Search:↓

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

The combination treatment showed a higher response rate but no significant survival benefits.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Etanercept effectively treated a severe skin condition when other treatments failed.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Tofacitinib taken by mouth helps treat hair loss in children.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Long-term high-dose fluconazole can cause reversible hair loss.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.